New drug takes aim at Hard-to-Treat cancers that reach the brain
Disease control
Recruiting now
This early-stage study tests an experimental drug called AO-252 in people with advanced solid tumors (cancers) that have spread to the brain or other parts of the body. The main goals are to check the drug's safety and find the best dose. About 86 adults whose cancer has not resp…
Phase: PHASE1 • Sponsor: A2A Pharmaceuticals Inc. • Aim: Disease control
Last updated May 11, 2026 20:39 UTC